Snapshot · Huberman Lab
The brain maps all relationships across space (physical proximity), time (when you expect to see them), and closeness (depth of attachment), all processed by the inferior parietal lobule.
Where this was said
At 7:00 · chapter starts 3:56
The experiment Huberman describes is elegant in its design and stunning in its result. Subjects in a brain scanner first viewed scenes of bowling balls arranged at varying distances — their brains were imaged as they processed changes in physical spacing. Next, they listened to sounds spaced at different temporal intervals — changes in timing, independent of the sounds themselves, lit up distinct circuits. Finally, subjects viewed photos of people ranging from complete strangers to close family members, at varying physical distances in the images. The key manipulation was emotional closeness: some photos were of people they loved deeply; others were celebrities or strangers. The finding that emerges is the episode's intellectual spine: changes in physical spacing, temporal spacing, and emotional closeness all activate the same brain area — the inferior parietal lobule [1] — Andrew Huberman "A landmark brain imaging experiment showed that changes in physical spacing of objects, temporal spacing of sounds, and emotional distance …" 03:57 . This is not a metaphor. The brain literally uses the same neural hardware to track where your keys are, when your alarm will ring, and how close you are to your mother.
A landmark brain imaging experiment showed that changes in physical spacing of objects, temporal spacing of sounds, and emotional distance between people all activate the same brain area — the inferior parietal lobule. This single finding reframes grief from a psychological mystery to a neurological remapping problem.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.